Prevalence and Characteristics of Onychomycosis in Patients with Knee Osteoarthritis: A Single-centre Prospective Cross-sectional Study
DOI:
https://doi.org/10.2340/00015555-3895Keywords:
onychomycosis, knee osteoarthritis, nail diseaseAbstract
Knee disorders that compromise patients’ lower leg movements and self-care may put these patients at greater risk of onychomycosis. However, little is known about the prevalence of onychomycosis in patients with knee diseases. This study evaluated the prevalence and characteristics of onychomycosis in patients with knee osteoarthritis. A total of 520 consecutive patients with symptomatic knee osteoarthritis who visited the Department of Orthopedics for a potential knee surgery were evaluated for onychomycosis by PCR-based reverse blot hybridization assay. Of the 520 patients, 308 (59.2%) were diagnosed with onychomycosis. Age (p = 0.004), male sex (p = 0.015), and being barefooted (p = 0.031) were statistically significant risk factors for onychomycosis. Knee disease severity, based on Kellgren-Lawrence grade, was associated with severity of onychomycosis. The impairment of physical function and self-care caused by knee disorders may increase the prevalence of onychomycosis in these patients.
Downloads
References
Welsh O, Vera-Cabrera L, Welsh E. Onychomycosis. Clin Dermatol 2010; 28: 151–159.
Faergemann J, Baran R. Epidemiology, clinical presentation and diagnosis of onychomycosis. Br J Dermatol 2003; 149: 1–4.
Sigurgeirsson B, Baran R. The prevalence of onychomycosis in the global population: a literature study. J Eur Acad Dermatol Venereol 2014; 28: 1480–1491.
Burzykowski T, Molenberghs G, Abeck D, Haneke E, Hay R, Katsambas A, et al. High prevalence of foot diseases in Europe: results of the Achilles project. Mycoses 2003; 46: 496–505.
Watanabe S, Harada T, Hiruma M, Iozumi K, Katoh T, Mochizuki T, et al. Epidemiological survey of foot diseases in Japan: results of 30,000 foot checks by dermatologists. J Dermatol 2010; 37: 397–406.
Effendy I, Lecha M, Feuilhade de Chauvin M, Di Chiacchio N, Baran R, European Onychomycosis O. Epidemiology and clinical classification of onychomycosis. J Eur Acad Dermatol Venereol 2005; 19: 8–12.
Thomas J, Jacobson GA, Narkowicz CK, Peterson GM, Burnet H, Sharpe C. Toenail onychomycosis: an important global disease burden. J Clin Pharm Ther 2010; 35: 497–519.
Gupta AK , Mays RR. The impact of onychomycosis on quality of life: a systematic review of the available literature. Skin Appendage Disorders 2018; 4: 208–216.
Scher RK. Onychomycosis: a significant medical disorder. J Am Acad Dermatol 1996; 35: S2–S5.
Gupta AK, Konnikov N, MacDonald P, Rich P, Rodger NW, Edmonds MW, et al. Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey. Br J Dermatol 1998; 139: 665–671.
Gupta AK, Jain HC, Lynde CW, Macdonald P, Cooper EA, Summerbell RC. Prevalence and epidemiology of onychomycosis in patients visiting physicians’ offices: a multicenter Canadian survey of 15,000 patients. J Am Acad Dermatol 2000; 43: 244–248.
Cozzani E, Agnoletti AF, Speziari S, Schiavetti I, Zotti M, Persi A, et al. Epidemiological study of onychomycosis in older adults with onychodystrophy. Geriatr Gerontol Int 2016; 16: 486–491.
Elewski BE, Charif MA. Prevalence of onychomycosis in patients attending a dermatology clinic in Northeastern Ohio for other conditions. Arch Dermatol 1997; 133: 1172–1173.
Papini M, Piraccini BM, Difonzo E , Brunoro A. Epidemiology of onychomycosis in Italy: prevalence data and risk factor identification. Mycoses 2015; 58: 659–664.
Takehara K, Oe M, Tsunemi Y, Nagase T, Ohashi Y, Iizaka S, et al. Factors associated with presence and severity of toenail onychomycosis in patients with diabetes: a cross-sectional study. Int J Nurs Stud 2011; 48: 1101–1108.
Elewski BE. Onychomycosis. Am J Clin Dermatol 2000; 1: 19–26.
Dabakaroff L, Mayorga TA , Markinson BC. The podiatric physician perspective. In: Rigopoulos D, Elewski B, Richert B, editors. Onychomycosis. Chichester, UK: Wiley-Blackwell; 2018: p. 197–205.
Guccione AA, Felson DT, Anderson JJ, Anthony JM, Zhang Y, Wilson PW, et al. The effects of specific medical conditions on the functional limitations of elders in the Framingham study. Am J Public Health 1994; 84: 351–358.
Zambon S, Siviero P, Denkinger M, Limongi F, Victoria Castell M, van der Pas S, et al. Role of osteoarthritis, comorbidity, and pain in determining functional limitations in older populations: European project on osteoarthritis. Arthritis Care Res (Hoboken) 2016; 68: 801–810.
Messier SP, Loeser RF, Hoover JL, Semble EL, Wise CM. Osteoarthritis of the knee: Effects on gait, strength, and flexibility. Arch Phys Med Rehabil 1992; 73: 29–36.
Fernando DJS, Masson EA, Veves A , Boulton AJM. Relationship of limited joint mobility to abnormal foot pressures and diabetic foot ulceration. Diabetes Care 1991; 14: 8–11.
Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988; 15: 1833–1840.
Insall JN, Ranawat CS, Aglietti P , Shine J. A comparison of four models of total knee-replacement prostheses. J Bone Joint Surg Am 1976; 58: 754–765.
Insall JN, Dorr LD, Scott RD , Scott WN. Rationale of the Knee Society clinical rating system. Clin Orthop Relat Res 1989: 13–14.
Tegner Y, Lysholm J. Rating systems in the evaluation of knee ligament injuries. Clin Orthop Relat Res 1985; 198: 43–49.
Kellgren JH , Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957; 16: 494-502.
Sergeev AY, Gupta AK, Sergeev YV. The Scoring Clinical Index for Onychomycosis (SCIO index). Skin Therapy Lett 2002; 7: 6–7.
Thomas J, Jacobson GA, Narkowicz CK, Peterson GM, Burnet H , Sharpe C. Toenail onychomycosis: an important global disease burden. J Clin Pharm Ther 2010; 35: 497–519.
Cathcart S, Cantrell W , Elewski B. Onychomycosis and diabetes. J Eur Acad Dermatol Venereol 2009; 23: 1119–1122.
Felson DT, Zhang Y, Hannan MT, Naimark A, Weissman BN, Aliabadi P, et al. The incidence and natural history of knee osteoarthritis in the elderly, the Framingham osteoarthritis study. Arthritis Rheum 1995; 38: 1500–1505.
Cho HJ, Chang CB, Kim KW, Park JH, Yoo JH, Koh IJ, et al. Gender and prevalence of knee osteoarthritis types in elderly Koreans. J Arthroplasty 2011; 26: 994–999.
Lee JH, Lee HJ, Han KD, Seo HM, Bang CH, Lee JY, et al. Prevalence of onychomycosis in Korea: a nationwide population-based study. J Mycol Infect 2018; 23: 63–67.
Sinikumpu S-P, Jokelainen J, Haarala AK, Keränen M-H, Keinänen-Kiukaanniemi S, Huilaja L. The high prevalence of skin diseases in adults aged 70 and older. J Am Geriatr Soc 2020; 68: 2565–2571.
Hame SL , Alexander RA. Knee osteoarthritis in women. Curr Rev Musculoskelet Med 2013; 6: 182–187.
Gill D , Marks R. A review of the epidemiology of tinea unguium in the community. Australas J Dermatol 1999; 40: 6–13.
Weinberg JM, Koestenblatt EK, Tutrone WD, Tishler HR,
Najarian L. Comparison of diagnostic methods in the evaluation of onychomycosis. J Am Acad Dermatol 2003; 49: 193–197.
Park SD, Lee G, Wang HY, Park M, Kim S, Kim H, et al. Evaluation of PCR-reverse blot hybridization assay, REBA sepsis-ID test, for simultaneous identification of bacterial pathogens and mecA and van genes from blood culture bottles. Ann Lab Med 2014; 34: 446–455.
Park SY, Kim BK, Wang HY, Kim SH, Kim HJ, Lee HY, et al. PCR-reverse blot hybridization assay for fast and accurate identification of causative species in superficial fungal infections. Clin Exp Dermatol 2016; 41: 359–365.
Choi Y, Wang H-Y, Lee G, Park S-D, Jeon B-Y, Uh Y, et al. PCR-reverse blot hybridization assay for screening and identification of pathogens in sepsis. J Clin Microbiol 2013; 51: 1451–1457.
Bergmans AM, Schouls LM, van der Ent M, Klaassen A, Böhm N , Wintermans RG. Validation of PCR-reverse line blot, a method for rapid detection and identification of nine dermatophyte species in nail, skin and hair samples. Clin Microbiol Infect 2008; 14: 778–788.
Published
How to Cite
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
